• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAnTHER Cub 研究:降钙素原指导儿童和青少年癌症中性粒细胞减少性发热患者的抗生素治疗——一项单臂先导研究。

PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study.

机构信息

Department of Paediatric Haematology and Oncology, Leeds Children's Hospital, Leeds, UK

Centre for Reviews and Dissemination, University of York, York, UK.

出版信息

BMJ Paediatr Open. 2022 Mar;6(1). doi: 10.1136/bmjpo-2021-001339.

DOI:10.1136/bmjpo-2021-001339
PMID:36053620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928328/
Abstract

BACKGROUND

Febrile neutropenia (FN) is a common complication of cancer treatment in children and young people, and many episodes are over-treated. Procalcitonin, may be an appropriate tool to guide the stopping of antibiotics in those at low risk of serious bacterial infection. Supportive care trials in this population have proven to be difficult to undertake. This single-arm pilot study aimed to evaluate whether a study using a procalcitonin-guided stopping-rule for antibiotics in paediatric FN is possible.

METHODS

Daily procalcitonin levels were performed during episodes of FN and clear guidance given for antibiotic discontinuation. Episode data and quantitative feasibility data were collected alongside interviews with professionals and ethnographic observations. Analysis was descriptive.

RESULTS

Of 32 patients and families approached, 28 patients consented, and 13 had febrile neutropenia. In total, 16 episodes were included in the study. All relevant FN episodes had data captured, with adequate data collection. There were no significant safety events. In 4/8 (50%) of episodes without clear microbiologically documented or clinical infection, antibiotics were reduced in duration or in spectrum. Interviews with professionals revealed the importance of the research, the value of key individuals in the study team, particular challenges of this protocol and suggestions for study improvements.

CONCLUSIONS

Studies to evaluate procalcitonin-guided approaches to stopping antibiotics in paediatric FN are possible.

摘要

背景

发热性中性粒细胞减少症(FN)是儿童和青少年癌症治疗的常见并发症,许多病例都过度治疗了。降钙素原可能是指导低风险严重细菌感染患者停止使用抗生素的合适工具。在该人群中进行的支持性护理试验已被证明难以进行。这项单臂试验旨在评估在儿科 FN 中使用降钙素原指导抗生素停药规则的研究是否可行。

方法

在 FN 发作期间每天进行降钙素原检测,并为抗生素停药提供明确指导。收集病例数据和定量可行性数据,并对专业人员进行访谈和民族志观察。分析是描述性的。

结果

在接触的 32 名患者和家属中,有 28 名患者同意,其中 13 名患有发热性中性粒细胞减少症。共有 16 个病例纳入研究。所有相关的 FN 病例均有数据记录,且数据收集充足。没有发生重大安全事件。在 8 例(50%)无明确微生物学记录或临床感染的病例中,抗生素的使用时间或种类减少。对专业人员的访谈揭示了研究的重要性、研究团队中关键人员的价值、该方案的特殊挑战以及对研究改进的建议。

结论

评估降钙素原指导儿科 FN 中停止使用抗生素的方法的研究是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ca/8928328/b5691101c366/bmjpo-2021-001339f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ca/8928328/c03946463566/bmjpo-2021-001339f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ca/8928328/b5691101c366/bmjpo-2021-001339f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ca/8928328/c03946463566/bmjpo-2021-001339f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ca/8928328/b5691101c366/bmjpo-2021-001339f02.jpg

相似文献

1
PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study.PAnTHER Cub 研究:降钙素原指导儿童和青少年癌症中性粒细胞减少性发热患者的抗生素治疗——一项单臂先导研究。
BMJ Paediatr Open. 2022 Mar;6(1). doi: 10.1136/bmjpo-2021-001339.
2
Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study).降钙素原指导下早期停用抗生素治疗在接受癌症化疗且有低风险发热性中性粒细胞减少症儿童中的安全性:一项随机可行性试验(ProFenC研究)
Pediatr Hematol Oncol. 2024;41(2):89-102. doi: 10.1080/08880018.2023.2249940. Epub 2023 Sep 1.
3
Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.癌症患者发热性中性粒细胞减少症中抗生素早期停用与持续使用至中性粒细胞减少症缓解的比较。
Cochrane Database Syst Rev. 2019 Jan 3;1(1):CD012184. doi: 10.1002/14651858.CD012184.pub2.
4
Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT.生物标志物指导确诊或疑似细菌感染住院儿童抗生素治疗疗程的有效性:BATCH随机对照试验
Health Technol Assess. 2025 May;29(16):1-125. doi: 10.3310/MBVA3675.
5
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.降钙素原指导在危重症患者中缩短抗生素治疗时间的疗效和安全性:一项随机、对照、开放标签试验。
Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.
6
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.一种用于预测癌症治疗儿童发热性中性粒细胞减少症期间严重感染风险的新临床决策规则(DISCERN-FN)的决策树推导及外部验证
Lancet Child Adolesc Health. 2022 Apr;6(4):260-268. doi: 10.1016/S2352-4642(21)00337-0. Epub 2021 Dec 3.
7
Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.降钙素原指导方案对发热性中性粒细胞减少症的抗生素治疗管理无效:一项随机对照试验。
Ann Hematol. 2016 Jun;95(7):1169-76. doi: 10.1007/s00277-016-2639-5. Epub 2016 Apr 27.
8
Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.评估血清降钙素原、血清白细胞介素-6 和白细胞介素-8 作为发热性中性粒细胞减少症和癌症患儿严重感染的预测因子。
Indian J Cancer. 2021 Apr-Jun;58(2):185-189. doi: 10.4103/ijc.IJC_808_18.
9
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.癌症合并发热性中性粒细胞减少症患儿的极早期出院与早期出院及非早期出院的比较
Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD008382. doi: 10.1002/14651858.CD008382.pub2.
10
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.对患有发热性中性粒细胞减少症的癌症患儿降钙素原水平的前瞻性队列研究。
BMC Pediatr. 2017 Jan 5;17(1):2. doi: 10.1186/s12887-016-0766-8.

引用本文的文献

1
Procalcitonin-guided antibiotic therapy for pediatrics with infective disease: A updated meta-analyses and trial sequential analysis.降钙素原指导儿童感染性疾病抗生素治疗:更新的荟萃分析和试验序贯分析。
Front Cell Infect Microbiol. 2022 Sep 21;12:915463. doi: 10.3389/fcimb.2022.915463. eCollection 2022.

本文引用的文献

1
Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.重新评估和校准癌症合并发热性中性粒细胞减少症患儿细菌感染的预测指标。
EClinicalMedicine. 2020 Jun 15;23:100394. doi: 10.1016/j.eclinm.2020.100394. eCollection 2020 Jun.
2
What do families want to improve in the management of paediatric febrile neutropenia during anti-cancer treatment? Report of a patient/public involvement group.在抗癌治疗期间,家庭希望在小儿发热性中性粒细胞减少症的管理方面改善哪些方面?一个患者/公众参与小组的报告。
BMJ Paediatr Open. 2019 Mar 1;3(1):e000398. doi: 10.1136/bmjpo-2018-000398. eCollection 2019.
3
The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics.
急性外科和急性内科团队在抗生素决策方面的差异:一项关于文化和团队动态的民族志研究。
Clin Infect Dis. 2019 Jun 18;69(1):12-20. doi: 10.1093/cid/ciy844.
4
Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.降钙素原和白细胞介素-6 对癌症合并发热性中性粒细胞减少症患儿细菌感染的预测价值。
Support Care Cancer. 2018 Nov;26(11):3819-3826. doi: 10.1007/s00520-018-4249-3. Epub 2018 May 19.
5
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.PEPtalk2:一项比较 VZIG 和阿昔洛韦作为水痘暴露后预防(PEP)用于儿童癌症患者的试点随机对照试验结果。
Arch Dis Child. 2019 Jan;104(1):25-29. doi: 10.1136/archdischild-2017-314212. Epub 2018 May 5.
6
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.儿童癌症和造血干细胞移植受者发热与中性粒细胞减少管理指南:2017 年更新版。
J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1.
7
Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.儿童癌症患者发热和中性粒细胞减少的风险适应性治疗方法——一项全国多中心研究
Eur J Cancer. 2016 Jan;53:16-24. doi: 10.1016/j.ejca.2015.10.065. Epub 2015 Dec 14.
8
An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer.血清生物标志物在评估癌症中性粒细胞减少症儿童发热中的预测价值的更新系统评价和荟萃分析。
Pediatr Infect Dis J. 2013 Oct;32(10):e390-6. doi: 10.1097/INF.0b013e31829ae38d.
9
Procalcitonin as a marker of sepsis.降钙素原作为脓毒症的标志物。
Int J Antimicrob Agents. 2002 Jul;20(1):1-9. doi: 10.1016/s0924-8579(02)00047-x.
10
Evolving concepts of management of febrile neutropenia in children with cancer.癌症患儿发热性中性粒细胞减少症管理理念的演变
Med Pediatr Oncol. 2002 Aug;39(2):77-85. doi: 10.1002/mpo.10073.